Skip to main content
. Author manuscript; available in PMC: 2024 Jan 23.
Published in final edited form as: J Am Coll Cardiol. 2022 Sep 20;80(12):1115–1126. doi: 10.1016/j.jacc.2022.06.040

TABLE 4.

Characteristics of the Derivation and the Validation Samples

Derivation Sample (n = 1,015)
Validation Sample (n = 1,097)
Positive Genetic Test (n = 377) Negative Genetic Test (n = 638) P Value Positive Genetic Test (n = 289) Negative Genetic Test (n = 808) P Value
Male 251 (66.58) 444 (69.59) 0.318 209 (72.32) 526 (65.10) 0.025
Age at diagnosis, y 48.15 ± 14.35 51.20 ± 14.47 <0.001 44.72 ± 15.50 51.03 ± 14.39 <0.001
Baseline LVEF 32.22 ± 10.42 31.96 ± 10.48 0.741 33.13 ± 11.16 32.59 ± 10.84 0.548
FH of DCM 231 (61.27) 249 (39.03) <0.001 165 (57.09) 168 (20.79) <0.001
Skeletal muscle disease 23 (6.10) 13 (2.04) 0.001 10 (3.46) 5 (0.62) <0.001
Hypertension 85 (22.55) 255 (39.97) <0.001 50 (17.30) 267 (33.04) <0.001
Left bundle branch block 60 (15.92) 273(42.79) <0.001 39 (13.49) 269 (33.29) <0.001
Low QRS voltage limb leads 88 (23.34) 43 (6.74) <0.001 48 (16.61) 68 (8.42) <0.001

Values are n (%) or mean ± SD.

Abbreviations as in Table 1.